S&P 500 Industrials Sector SEC Filings — May 18, 2026

18-05-2026

Clough Global Dividend & Income Fund (GLV) filed a definitive proxy statement (DEF 14A) for a joint annual meeting of shareholders to be held virtually on July 6, 2026. The sole proposal for GLV shareholders is the election of one independent trustee nominee, Adam D. Crescenzi, for a three-year term expiring at the 2029 annual meeting. The filing also covers trustee elections for two affiliated funds (GLQ and GLO) and provides record date (May 8, 2026) and share counts: GLV has 12,409,682.8250 common shares outstanding. No financial results or period-over-period comparisons are included.

• · Joint annual meeting of GLV, GLQ, and GLO will be held virtually via telephone conference call on July 6, 2026 at 9:00 a.m. Mountain time.
• · Shareholders must register by email to shareholdermeetings@computershare.com no later than 5:00 p.m. Eastern Time on June 30, 2026 to participate.
• · The Board of each fund is divided into three classes with staggered three-year terms.
• · Each Fund's most recent annual report (fiscal year ended October 31, 2025) is available upon request.
• · Proxy materials available at https://www.proxy-direct.com/clo-35189.

18-05-2026

At Old National Bancorp's 2026 Annual Meeting held on May 13, 2026, shareholders elected all 12 director nominees, approved the non-binding advisory say-on-pay proposal, ratified Deloitte & Touche LLP as independent auditor for fiscal 2026, and approved the 2026 Equity Compensation Plan. Turnout was high, with approximately 92.5% (357,216,538 shares) of outstanding common stock represented. All proposals received strong support, with no contested issues.

• · All director nominees received between 97.4% and 99.8% of votes cast (excluding broker non-votes), with Daniel S. Hermann receiving the lowest support at 325,803,851 For (97.4%) and Thomas E. Salmon the highest at 333,719,522 For (99.8%).
• · The say-on-pay proposal passed with 319,063,115 For, 9,990,057 Against, and 5,315,303 Abstentions, representing approximately 95.4% of votes cast.
• · Ratification of Deloitte & Touche LLP as auditor was nearly unanimous: 356,245,176 For, 772,981 Against, 198,381 Abstentions.
• · The 2026 Equity Compensation Plan was approved with 319,941,218 For, 9,953,067 Against, 4,474,190 Abstentions (approx. 95.7% of votes cast).
• · Record date for the meeting was March 20, 2026.

18-05-2026

Global Business Travel Group, Inc. held its 2026 annual meeting on May 13, 2026, with 407,115,412 shares represented out of 523,342,918 entitled to vote. All four proposals passed with overwhelming shareholder support: the three Class I director nominees (Paul Abbott, Eric Hart, Kathleen Winters) were elected, the appointment of KPMG LLP as auditor was ratified, the advisory say-on-pay proposal was approved, and the amendment to the 2022 Equity Incentive Plan was adopted. The highest opposition was against the equity plan amendment with over 9.1 million votes against, but it still received approximately 96% support from votes cast.

• · The amendment to the 2022 Equity Incentive Plan received 390,956,846 votes for, 9,129,997 against, 3,640,938 abstain, and 3,387,631 broker non-votes, making it the proposal with the most opposition.
• · The advisory say-on-pay proposal had 402,377,712 votes for, 1,263,703 against, 86,366 abstain, and 3,387,631 broker non-votes.
• · Ratification of KPMG LLP as auditor had 406,430,176 votes for, 653,792 against, and 31,444 abstain, with no broker non-votes because it is a routine matter.
• · Total shares outstanding entitled to vote as of March 17, 2026: 523,342,918 shares of Class A common stock.

18-05-2026

Bally’s Corp reported Q1 2026 consolidated revenue of $755.7M, up 28.3% YoY, driven by strong growth in Bally's Intralot B2C (+31.0%) and North America Interactive (+35.9%). However, Casinos & Resorts EBITDAR grew only 1.2% to $96.2M due to elevated competition and higher shared services costs, while North America Interactive remained EBITDA-negative at $(7.1)M (though improving $0.9M YoY). The company advanced major projects including the Chicago casino topping out, the $4.0B Bally's Bronx development, and refinancing with a $1.1B credit facility and full repayment of the $1.47B term loan.

• · Bally's entered a new $1.1B credit facility due 2031 and completed sale-leaseback of Lincoln Casino Resort real estate to GLP Capital.
• · Proceeds from Intralot transaction, term loan, and sale-leaseback were used to fully repay the $1.47B term loan due 2028.
• · Casinos & Resorts growth was notably strong at Bally's Baton Rouge (landside Dec 2025) and Marquette (landside Feb 2026), partially offset by elevated competition in Shreveport and Dover.
• · Bally's Intralot B2B segment includes Intralot's B2B and B2G post-acquisition; legacy B2B EBITDAR was flat YoY despite US lottery revenue decline.
• · North America Interactive recorded negative Segment Adjusted EBITDAR of $7.1M, an improvement of $0.9M from prior year, driven by top-line growth and cost management.
• · Bally's holds a 38% equity interest in Star Entertainment following loan conversion in Q4 2025; Star refinanced with a $390M facility from WhiteHawk Capital Partners in May 2026.
• · UK online iGaming revenue grew 10.5% YoY in constant currency despite the higher remote gaming duty effective April 1, 2026; Bally's has a mitigation plan in place.
• · Spain B2C revenue remained stable at 1.7% YoY growth in constant currency.
• · The $500M New York license fee and $115M golf course contingent consideration were finalized in Q1 2026.
• · Bally's holds Minority Business Enterprise (MBE) certification from NMSDC.

18-05-2026

This definitive proxy statement (DEF 14A) solicits shareholder votes for the election of trustees at the joint annual meeting of Clough Global Equity Fund (GLQ) and two affiliated funds, scheduled for July 6, 2026. For GLQ, three independent trustees – Edmund J. Burke, Clifford J. Weber, and Vincent W. Versaci – are nominated for three-year terms expiring at the 2029 annual meeting. The filing includes meeting logistics, record date (May 8, 2026), and outstanding share counts, but contains no financial performance data or operational updates.

• · Joint annual meeting will be held virtually via telephone conference on July 6, 2026 at 9:00 a.m. Mountain Time.
• · Record date for shareholders entitled to vote is May 8, 2026.
• · Shareholders must register by emailing shareholdermeetings@computershare.com by 5:00 p.m. Eastern Time on June 30, 2026 to participate.
• · GLQ has 18,738,120.8920 common shares outstanding; GLV has 12,409,682.8250 shares; GLO has 42,766,222.3190 shares.
• · All GLQ nominees are independent trustees; GLQ's three nominees (Burke, Weber, Versaci) are all current Class III trustees standing for re-election.
• · GLV elects one trustee (Adam D. Crescenzi); GLO elects two trustees (DiGravio and McNally).
• · Quorum requires a majority of shares entitled to vote present or by proxy.
• · If no contrary instructions, proxies will be voted FOR all nominees.
• · The funds' most recent annual report (fiscal year ended Oct 31, 2025) is available upon request.

18-05-2026

Bally's Chicago, Inc. reported Q1 2026 revenue of $33.1M, up 13.1% from $29.3M in the combined Q1 2025 (predecessor + successor periods). Net loss attributable to the company narrowed significantly to $7.8M from $23.2M in the prior year period. However, cash used in operations surged to $64.5M from $17.2M, driven by a large increase in accounts receivable and other assets, and the company's reliance on parent financing grew as due to Bally's Corporation rose to $85.9M from $19.6M at year-end. Total stockholders' deficit deepened to $142.7M from $134.9M.

• · Accounts receivable, net increased to $83.4M at March 31, 2026 from $64.8M at December 31, 2025, largely due to $81.6M due from GLP.
• · Due to related party (Bally's Corporation) surged from $19.6M to $85.9M, indicating increased short-term financing from the parent.
• · Redeemable non-controlling interest decreased from $511.8M to $491.9M, reflecting net loss allocation of $19.9M.
• · Capital expenditures were only $0.7M in Q1 2026 versus $33.9M in combined Q1 2025, suggesting a slowdown in investment.
• · The company had $13.1M cash at quarter end, up from $12.0M at year-end, but still low relative to cash burn.

18-05-2026

Ideal Power announced a $30.0 million registered direct offering of 5,291,005 shares of common stock (or equivalents) priced at market under Nasdaq rules, expected to close on May 18, 2026. The company intends to use net proceeds to advance commercialization of its B-TRAN bidirectional semiconductor power switch, including customer design-ins, custom development programs, and initial production ramp with strategic partners. While the offering strengthens the balance sheet at a pivotal moment, it will dilute existing shareholders.

• · The offering is made pursuant to an effective shelf registration statement on Form S-3 (No. 333-292492) declared effective on January 9, 2026.
• · A prospectus supplement and accompanying prospectus will be filed with the SEC.
• · The sole placement agent is Titan Partners, a division of American Capital Partners.
• · CEO David Somo highlighted accelerating demand for data centers and power as a driver for the financing.
• · Proceeds will also be used for general corporate and working capital purposes.
• · The offering is priced at market under Nasdaq rules, not a fixed per-share price.

18-05-2026

Brand Engagement Network Inc. entered into a definitive Reseller Agreement with Accelevate Solutions on May 14, 2026, granting its subsidiary SKYE AI USA, LLC exclusive rights to the African continent for an initial five-year term, subject to annual renewal based on minimum revenue thresholds. The licensor will receive 35% of gross revenue (excluding hardware) from sales. While this expands the company's footprint in Africa, the revenue-sharing obligation and performance-based renewal introduce future financial commitments and uncertainties.

• · The agreement includes a joint Pricing Committee and standard indemnification and confidentiality provisions.
• · Exclusive rights are subject to annual renewal based on minimum revenue thresholds for subsequent consecutive years.
• · The Company previously disclosed a letter agreement with Accelevate on April 22, 2026, which led to this definitive agreement.
• · The Company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

18-05-2026

Bitcoin Depot Inc. filed an 8-K on May 18, 2026, reporting multiple material events including a bankruptcy or receivership (Item 1.03), triggering events that accelerate direct financial obligations (Item 2.04), and departure of directors or officers (Item 5.02). The filing indicates a severe financial distress leading to bankruptcy proceedings, but specific financial details, dollar amounts, and names are not disclosed in the provided summary.

• · Filing includes multiple 8-K items (1.03, 2.04, 5.02, 7.01, 9.01) indicating a comprehensive material event.
• · Exact dollar amounts, share counts, and specific executive names are NOT_DISCLOSED in the provided summary.
• · Sector not specified; Bitcoin Depot Inc. is a Bitcoin ATM operator (known from public information, but not in filing).

18-05-2026

Artificial Intelligence Technology Solutions Inc. (AITX) announced via an 8-K filed on May 18, 2026, that its subsidiary RAD is launching SCANNA, a product designed to unlock smarter security from existing cameras. The announcement was made through a press release attached as Exhibit 99.1. No financial details were provided in this filing.

• · The press release is attached as Exhibit 99.1 to the Form 8-K.
• · The filing was made under Item 8.01 (Other Events) and Item 9.01 (Exhibits).

18-05-2026

Chiba Bank and Chiba Kogyo Bank have agreed on a 1:1 share transfer ratio for their management consolidation via a joint share transfer, forming Chiba Financial Group effective April 1, 2027. The consolidation targets FY2028 consolidated ROE of ~11%, profit attributable to owners of parent of ¥140B or more, and OHR around 40%. While Chiba Kogyo Bank has higher net assets per share (¥2,498 vs ¥1,781) and EPS forecast (¥135.48 vs ¥127.97), it pays a much lower dividend (¥10 vs ¥52), and its stock price has historically shown volatility due to speculation and a prior large shareholder stake. The 1:1 ratio falls within all valuation ranges provided by third-party appraisers.

• · Chiba Bank acquired 19.9% of Chiba Kogyo Bank shares from Ariake Capital on March 28, 2025
• · A memorandum of understanding was announced on September 29, 2025
• · The share transfer ratio of 1:1 was agreed after repeated negotiations, and falls within all three valuation ranges from both third-party appraisers (Mitsubishi UFJ Morgan Stanley Securities and Mizuho Securities)
• · Future elimination of outward preferred dividend flows through acquisition and cancellation of Chiba Kogyo Bank preferred shares is a positive factor for Chiba FG common shareholders
• · Target Tier 1 common equity capital ratio (Basel III full implementation finalization basis, excluding valuation differences on securities) of 10.5–11.5% for FY2028
• · Chiba Kogyo Bank's stock price had been volatile due to speculative reporting and the holding period by Ariake Capital, but such influences have diminished over time

18-05-2026

Estrella Immunopharma reported a net loss of $2.29M for Q1 2026, an 8.9% increase from $2.10M in Q1 2025, driven largely by a 28.5% surge in G&A expenses. However, the company improved its stockholders' deficit from ($10.37M) to ($5.27M) through a $7.24M net registered direct offering and reduced total liabilities by $4.62M, primarily by paying down $4.13M in related party accrued liabilities. Cash increased 39% to $1.93M, but operating cash burn widened dramatically to $6.70M from $0.47M year-over-year, signaling heavy near-term cash consumption.

• · R&D expenses were approximately 61% of total operating expenses in Q1 2026, with $1.375M from related party (same as prior year).
• · G&A expenses increased 28.5% YoY to $891,789, partly due to stock-based compensation of $146,714 in Q1 2026 vs $159,095 in Q1 2025.
• · The company issued 4,063,290 shares of common stock, prefunded warrants, and common stock warrants in a registered direct offering, generating gross proceeds of $7,999,988 but incurring $758,882 in transaction costs.
• · Warrants outstanding surged from 2,214,993 to 10,178,928, with 8,594,935 new warrants granted at a weighted average exercise price of $1.23 (down from $11.50).
• · Aggregate intrinsic value of stock options fell from $2.682M to $0.882M, indicating a significant drop in the company's stock price.
• · Net cash used in operating activities was $6.70M, largely due to a $4.125M payment of related party accrued liabilities.
• · The company had no revenue and remains in the development stage with an accumulated deficit of $39.28M.

18-05-2026

Irenic Capital Management LP filed its 13F-HR for the quarter ended March 31, 2026, disclosing a $1.54B portfolio across 47 holdings. The largest single position was a put option on iShares Russell 2000 ETF ($323.9M), followed by common stock in Snap Inc. ($138M) and Integer Holdings Corp. ($111.2M), indicating a concentrated, event-driven strategy with notable hedging through derivatives.

• · Total portfolio value of $1.54B as of March 31, 2026.
• · 47 holdings with 4 option positions (2 puts, 2 calls) and 2 convertible note positions.
• · Largest single holding is a put on iShares Russell 2000 ETF ($323.9M) – representing ~21% of portfolio.
• · Second-largest holding is Snap Inc. common stock ($138M), followed by Integer Holdings ($111.2M).
• · Irenic holds call options on First Solar ($42.5M) and Snap Inc. ($26.5M), and a put on Invesco QQQ ($37.3M).
• · The firm has positions in three SPACs: Highview Merger Corp., General Purpose Acquisition Corp., and Safeguard Acquisition Corp.
• · Convertible notes held: Bandwidth Inc. 0.5% due 2026 ($37.6M) and Par Technology Corp. 1.0% ($17.3M).

18-05-2026

Faraday Future announced $25M in new convertible note financing, bringing total financing to $70M over two months (including $45M from April), sufficient to support Phase 1 of its EAI robotics strategy by end of 2026. The company raised its full-year shipment target to 1,500 units and declared a shift from liquidity-driven to capital-structure-driven financing. However, only $12.5M is immediately available to the operating account; the remainder is in controlled accounts subject to conditions, and the company continues to face significant risks including insufficient share capital and Nasdaq compliance requirements.

• · SEC investigation concluded with no penalties.
• · Founding team has fully returned to the company.
• · The $25M convertible notes are unregistered and subject to trading restrictions.
• · Of the $25M, $12.5M is directly in the operating account; the remaining $12.5M is in controlled accounts with conditions for release.
• · The full strategic plan (upgraded from Ten-Punch Combo to Five Key Transformations) will be unveiled in YT's Investor Weekly Report on Sunday.
• · Key application scenarios: education, security inspection, reception and guided tours, performance, and university research.
• · Company expects to move EAI Vehicle business away from high-cost short-term funding toward operating cash flow, industry partnerships, and long-term capital.

18-05-2026

Banzai International, Inc. filed an 8-K/A on May 18, 2026, reporting a Floor Price Amendment (May 15, 2026) to its loan agreement with CP BF Lending. The floor price for converting the outstanding convertible note was reduced from $50.00 to $4.50 per share (post-1-for-20 reverse stock split), while the conversion price remains 95% of the prior trading day's closing price subject to that floor. As of May 14, 2026, the outstanding note balance was $5,361,910, reflecting ongoing dilution risk for existing shareholders.

• · The Floor Price Amendment reduces the conversion floor from $50.00 to $4.50 (post-split), with conversion price at 95% of prior day's closing price subject to floor.
• · CP BF agreed to use commercially reasonable efforts to partially convert the note, with daily volume limit of 5% of aggregate daily trading volume (waivable by company).
• · A Suspension Period applies after the company pays at least $2M of the note's balance, suspending prepayment of proceeds from securities sales until 60 days or $10M gross proceeds received.
• · As of May 14, 2026, the outstanding note balance was $5,361,910, down from $10,758,774.75 at issuance.
• · Company failure to comply with Floor Price Amendment constitutes an Event of Default.

18-05-2026

18-05-2026

SkyBridge Capital II, LLC filed its 13F-HR for the quarter ended March 31, 2026, disclosing a portfolio valued at $13.13 billion. The portfolio is heavily concentrated in cryptocurrency-related assets, with Strategy Inc (formerly MicroStrategy) and iShares Bitcoin Trust comprising approximately 97% of total holdings. Other positions include Chime Financial, Circle Internet Group, and Klarna Group.

• · The portfolio is heavily concentrated: Strategy Inc and iShares Bitcoin Trust together represent about $12.8 billion, or 97% of total holdings.
• · No options, warrants, or derivative instruments were reported; all holdings are common shares or ETF shares.
• · The filing does not provide prior period comparisons, so no quarter-over-quarter changes are available.

18-05-2026

LanzaTech Global, Inc. entered into a securities purchase agreement to sell 2,000,000 shares of common stock at $10.00 per share in a registered direct offering, generating gross proceeds of $20.0 million. Concurrently, the company amended its existing subscription agreement with LanzaTech Global SPV, LLC, lowering the cash balance threshold for additional share purchases from $40 million to $30 million. Net proceeds from the offering will be used for general corporate purposes.

• · The offering was conducted under an effective shelf registration statement on Form S-3 (File No. 333-279239).
• · Closing of the offering is expected on May 18, 2026.
• · The PIPE subscription amendment also provided that LT Global consented to the offering in connection with its consent rights over future financings.
• · The Company has until May 13, 2027, to require LT Global to purchase up to an additional $20.0 million of shares, subject to the lowered cash requirement of $30 million.

18-05-2026

Design Therapeutics, Inc. filed an 8-K on May 18, 2026, under Item 8.01 (Other Events). No specific details about the event, financial impact, or strategic implications are disclosed in the available filing summary. Without access to the full filing content, no material facts can be extracted or analyzed.

18-05-2026

ABVC Biopharma reported no revenue for Q1 2026, with net loss widening to $1,689,937 from $944,190 in Q1 2025, a 79% increase. Operating expenses surged 127% to $1,572,472, driven primarily by a 1,514% jump in stock-based compensation ($787,374 vs $48,773). Cash and cash equivalents plummeted 79% to $140,324 from $681,480, and total assets declined 6.3% to $19.7 million, reflecting continued cash burn with no top-line revenue.

• · Cash burn accelerated: net cash used in operations was $894,243 in Q1 2026 vs $539,833 in Q1 2025, a 65.7% increase.
• · Total current assets fell 74.1% to $648,848 from $2,501,343, driven by declines in cash and due from related parties.
• · Short-term bank and other loans decreased 88.3% to $88,737 from $755,512, while convertible notes payable remained unchanged.
• · Accumulated deficit grew to $78,418,603 from $76,858,361, reflecting continued losses.
• · No revenue was generated in either period; the company remains pre-revenue.
• · Stock-based compensation of $787,374 represents 50% of total operating expenses in Q1 2026, up from 7% in Q1 2025.

18-05-2026

Catheter Precision, Inc. reported Q1 2026 total revenues of $432K, a 202% increase from $143K in Q1 2025, driven by strong growth in Cardiac Electrophysiology product sales ($248K vs $143K) and the addition of a Private Aviation service segment ($184K). Net loss attributable to common stockholders improved to ($3,041K) from ($4,045K), and operating loss narrowed 35% to ($2,318K). However, cash used in operations increased 20% to ($2,796K), and the company ended the quarter with $441K in cash, down from $450K a year earlier. The quarter included an acquisition of a private aviation business, contributing $1.2M in cash outflow and adding $184K in service revenue.

• · The company acquired a private aviation business during Q1 2026, paying $1.2M in cash and issuing $4.8M in short-term notes and $5.8M in deferred consideration.
• · Goodwill increased from $0 to $9.7M and intangible assets from $15.2M to $22.3M due to the acquisition.
• · Private Aviation segment contributed $184K in service revenue (Luxe $42K, Hops $142K) and a segment net loss of $132K.
• · Cardiac Electrophysiology segment net loss was $1,558K, compared to total company net loss of $4,045K in Q1 2025 (prior period had no Private Aviation).
• · The company issued 392,608 shares of common stock and equity-classified contracts for $3.7M in proceeds during Q1 2026.
• · A deemed dividend of $1,360K was recorded on a warrant inducement offer.
• · Total liabilities increased to $25.9M from $9.2M, primarily due to acquisition-related debt.
• · The company had $9.2M in Level 3 fair value liabilities (royalties payable, deferred consideration, convertible notes).

18-05-2026

Regency Centers Corporation filed an 8-K to announce the availability of an updated investor presentation for use at conferences and meetings beginning May 18, 2026. The presentation is accessible through the investor relations section of the company's website.

• · The presentation is available at investors.regencycenters.com.
• · The filing includes both Regency Centers Corporation and Regency Centers, L.P. as registrants.
• · Information furnished under Item 7.01 is not deemed 'filed' for purposes of Section 18 of the Exchange Act.

18-05-2026

Cottonwood Communities, Inc. disclosed the issuance of 257,866 shares of its Series 2025 Preferred Stock between April 22 and May 17, 2026, raising $2,541,000 in net proceeds after commissions and fees. The offering, launched December 9, 2024, has a maximum of $150,000,000 and remains ongoing. As of May 17, 2026, 11,314,733 shares of Series 2025 Preferred Stock were outstanding.

• · Offering launched December 9, 2024, with a maximum of $150,000,000 in shares.
• · Purchase price is $10.00 per share with discounts available to certain categories of purchasers.
• · The offering is conducted under Rule 506(b) of Regulation D, exempt from registration, and limited to accredited investors without general solicitation.
• · Selling commissions of $117,060 and aggregate placement fees of $78,077 were paid in connection with the share sales.

18-05-2026

ICU Medical filed an 8-K to announce the adoption of an Amended and Restated Certificate of Incorporation, approved by the Board and stockholders, effective May 15, 2026. The amendment restates and integrates prior provisions, updates authorized shares (80M common, 500k preferred), and clarifies governance terms including one-year director terms, removal with or without cause, prohibition of stockholder action by written consent, and a 25% threshold for stockholders to call special meetings. No financial impact is disclosed.

• · The original certificate of incorporation was filed on January 9, 1992.
• · Director terms are one year, expiring at the next annual meeting; directors may be removed with or without cause.
• · Stockholders are expressly prohibited from acting by written consent.
• · The Board of Directors has the authority to amend the Bylaws without stockholder approval.
• · Director liability is eliminated to the fullest extent permitted by Delaware law.

18-05-2026

Tanaka Capital Management Inc filed its 13F-HR for the quarter ended March 31, 2026, disclosing 44 equity holdings with a total reported value of approximately $60.0 million (based on sum of reported values). The largest positions by value include United States Antimony ($5.4M), NexGen Energy ($5.1M), Nvidia ($4.3M), Corcept Therapeutics ($4.5M), Aura Minerals ($4.1M), Nuvation Bio ($3.9M), and Apple ($3.3M). The portfolio shows significant concentration in mining/energy (uranium, antimony) and pharmaceuticals, with limited allocation to traditional large-cap consumer staples.

• · Tanaka Capital Management holds significant positions in speculative/pre-revenue names: Fuelnation (251,150 shares, $0 value), Electrovaya (253,930 shares, $2.0M), and Intellia Therapeutics (220,107 shares, $2.8M).
• · The portfolio has notable exposure to uranium plays: Cameco ($2.3M) and Uranium Energy Corp ($1.0M) in addition to NexGen Energy.
• · Top ten holdings concentrate approximately 55% of portfolio value in 6 stocks: US Antimony, NexGen, Corcept, Nvidia, Aura Minerals, and Nuvation Bio.
• · Only 3 positions exceed $5M in value; the median position value is approximately $0.5M.
• · Traditional large-cap holdings (Apple, Mastercard, PepsiCo, etc.) are relatively small in portfolio weight.
• · Fuelnation, Inc. is listed with $0 value despite 251,150 shares, suggesting it may be a defunct or penny stock.

18-05-2026

FedEx Freight Holding Company, Inc. filed an 8-K under Item 5.02, including cautionary forward-looking statements regarding its planned tax-free separation of the FedEx Freight business into a new publicly traded company. The filing was signed by C. Edward Klank III as President, though no specific officer departure or election details were provided in the content.

• · The filing date is May 18, 2026, with an event date of May 14, 2026.
• · The forward-looking statements include risks such as potential uncertainty during the pendency of the separation, possibility the separation will not be completed on time or at all, and potential disruption to existing business relationships.
• · The filing references a Registration Statement on Form 10 filed in connection with the separation.

18-05-2026

Addentax Group Corp. completed the acquisition of Time Is Loan Limited on May 15, 2026, through its wholly owned subsidiary Yingxi Industrial Chain Investment Co., Ltd. The acquisition was executed via a share exchange agreement dated April 22, 2026, with the seller, Ms. OR Shan Shan, receiving 137,790 shares of Addentax common stock. The shares were issued under Regulation S exemption, and no cash consideration or financial terms were disclosed.

• · The Share Exchange Agreement was originally filed as an exhibit to an 8-K on April 28, 2026.
• · The issuance of shares was exempt from registration under Regulation S (offshore transaction, non-U.S. person seller).
• · No financial terms (e.g., revenue, profit, valuation) of the target or acquisition were disclosed in this filing.

18-05-2026

Union Pacific Corporation held its Annual Meeting of Shareholders on May 14, 2026, with a quorum of 90.76% (538,870,394 shares present out of 593,678,300 outstanding). Shareholders approved all three proposals: election of 11 directors, ratification of Deloitte & Touche LLP as auditor for 2026, and an advisory vote on executive compensation (Say on Pay). However, several directors faced notable opposition, with Michael R. McCarthy receiving the most votes against (25,893,643), and the Say on Pay proposal had 24,436,114 votes against, indicating some shareholder dissent.

• · Director Michael R. McCarthy received the highest votes against (25,893,643), followed by Jane H. Lute (21,204,940).
• · Ratification of Deloitte & Touche LLP as auditor passed with 506,109,723 votes for, 31,880,708 against.
• · Say on Pay proposal had 454,118,030 votes for, 24,436,114 against, and 2,241,179 abstentions.
• · All director elections had 58,075,071 broker non-votes, which are not counted as votes for or against under NYSE rules.

18-05-2026

FedEx Corporation announced the resignation of Guy M. Erwin II, Corporate Vice President and Chief Accounting Officer, effective May 31, 2026, to join FedEx Freight Holding Company as Senior Vice President – Chief Accounting Officer. The resignation is not due to any disagreement with the company. Claude F. Russ, currently Enterprise Vice President, Finance and recently named Interim Chief Financial Officer effective June 1, 2026, will serve as Interim Chief Accounting Officer effective June 1, 2026, until a permanent successor is appointed.

• · Mr. Erwin will continue in his current role until May 31, 2026.
• · Mr. Russ has served as Enterprise Vice President, Finance since June 2024 and previously held various senior roles at FedEx Dataworks and FedEx Freight.
• · No family relationship between Mr. Russ and any director or executive officer, and no transactions subject to Item 404(a) of Regulation S-K.

18-05-2026

MediaAlpha, Inc. announced the appointment of Lauren StClair to its Board of Directors effective May 15, 2026. Ms. StClair brings over 20 years of technology finance leadership, currently serving as CFO of Slice Technologies and previously as CFO of NerdWallet and senior finance roles at eBay. She will also join the Audit Committee.

• · Ms. StClair holds a Bachelor of Science from Stanford University and an MBA from Duke University's Fuqua School of Business.
• · MediaAlpha operates with more than 1,150 active partners and generated over 141 million Consumer Referrals in 2025.
• · Ms. StClair has over 20 years of finance leadership at technology and digital-commerce companies.
• · Prior to Slice Technologies, she spent more than four years as CFO of NerdWallet (Nasdaq: NRDS).
• · Her earlier career includes 13 years at eBay in roles such as CFO of eBay North America and CFO/Interim GM of StubHub International.
• · The appointment is effective May 15, 2026, and Ms. StClair will also serve on the Audit Committee.

18-05-2026

Tofutti Brands reported a net loss of $255K for Q1 2026, worsening from a $162K loss in Q1 2025, driven by a 2.1% decline in net sales to $1,557K and a 20.4% drop in gross profit to $469K. Operating cash flow turned negative at ($279)K versus positive $148K a year ago, and cash on hand plunged to $63K from $347K at year-end. All key metrics deteriorated, with no bright spots.

• · Total inventory increased to $1,936K from $1,729K, driven by a jump in raw materials and packaging ($948K vs $571K) while finished products declined ($988K vs $1,158K).
• · Accounts receivable decreased to $763K from $915K (net of allowances).
• · Total liabilities rose slightly to $1,180K from $1,176K, while stockholders' equity fell to $1,953K from $2,208K due to the net loss.
• · Weighted average shares outstanding remained constant at 5,154,706 (basic and diluted).
• · Interest paid was $0 compared to $1K in the prior year period.
• · No income tax provision was recorded for the prior year period; Q1 2026 shows a $1K provision.

18-05-2026

Builders FirstSource announced a planned leadership succession: Mike Hiller appointed COO-Designate to succeed Steve Herron, who will retire on December 31, 2026. Additionally, Coley O'Brien was appointed Chief Human Resources Officer, succeeding Hiller. The transitions are part of a planned succession to ensure continuity and leverage internal and external talent.

• · Steve Herron joined Builders FirstSource through the 2015 acquisition of ProBuild Holdings and has over 40 years of industry experience.
• · Mike Hiller previously served as Vice President of BMC's Intermountain Region before the 2021 merger, later became President of the Central Division, and most recently was Chief Talent Officer.
• · Coley O'Brien joins from The Wendy's Company, where he served as Chief People Officer since 2007 leading global HR strategy.
• · Builders FirstSource is headquartered in Irving, Texas, operates ~570 locations across 43 states, and serves 48 of the top 50 CBSAs.

18-05-2026

Babcock & Wilcox Enterprises announced the pricing of an underwritten public offering of 10,810,811 shares of common stock at $18.50 per share, with gross proceeds of approximately $200 million. The net proceeds will be used to prepay and reborrow under its Credit Agreement to fund project-related capital, working capital, growth initiatives including AI data center power generation and BrightLoop technology commercialization, potential acquisitions, and balance sheet strengthening. The offering, led by B. Riley Securities, is expected to close on May 18, 2026, but will dilute existing shareholders may face dilution from the new shares and the underwriters' 30-day option to purchase an additional 15%.

• · The offering is being made under a shelf registration statement effective April 8, 2025.
• · Underwriters have a 30-day option to purchase up to an additional 15% of the shares at the public offering price less discounts.
• · B. Riley Securities is the lead book-running manager; Craig-Hallum and Lake Street Capital Markets are joint book-running managers; Northland Capital Markets is co-manager.
• · The offering is expected to close on May 18, 2026.
• · Use of proceeds includes prepaying Credit Agreement amounts and reborrowing to fund project-related capital and working capital needs for steam turbine and boiler production capacity.

18-05-2026

ArcBest Corporation filed an amendment (8-K/A) to correct a clerical error on the cover page of its May 15, 2026, 8-K, which had incorrectly listed its state of incorporation as Delaware instead of Texas following the company's conversion from Delaware to Texas. This amendment does not modify any other disclosure and has no financial or operational impact.

18-05-2026

Farmer Mac held its Annual Meeting on May 14, 2026. Stockholders elected all ten director nominees, ratified PricewaterhouseCoopers LLP as independent auditor for 2026 (1,132,859 votes for vs. 108,540 against), and approved the advisory say-on-pay proposal (918,463 for vs. 101,861 against). The four directors appointed by the President of the United States continue in office.

• · Class A stockholders elected five directors: Engebretsen (606,312 votes for), Logan (503,092), McKissack (503,092), Plagge (503,592), Ware (502,985); broker non-votes of 108,522 each.
• · Class B stockholders elected five directors: Crawford (627,479.5 votes for), Gales (435,302), Riel (627,817), Sexton (123,427), Shaw (627,479.5); no broker non-votes.
• · Ratification of PwC had 1,132,859 votes for, 108,540 against, 63,680 abstain, no broker non-votes.
• · Say-on-pay advisory vote had 918,463 for, 101,861 against, 75,960 abstain, 108,522 broker non-votes.
• · Farmer Mac intends to hold future advisory say-on-pay votes annually.
• · The four presidentially appointed directors (Junkins, Wilcher, Faivre, Stones) have no specified term and serve at the pleasure of the President.

18-05-2026

Nicolet Bankshares held its 2026 annual meeting on May 18, 2026, with all 12 director nominees elected and the ratification of Forvis Mazars, LLP as auditor passing overwhelmingly. However, the non-binding advisory vote on executive compensation (say-on-pay) showed significant shareholder dissent, with approximately 32.7% of votes cast against the proposal (4,938,131 Against vs 10,078,861 For).

• · All 12 director nominees were elected with For votes ranging from 13,750,490 (John N. Dykema) to 14,910,311 (Glen E. Tellock); the lowest For percentage (excluding broker non-votes) was 91.0% for John N. Dykema.
• · Auditor ratification received 16,862,884 For votes vs 31,390 Against and 35,540 Abstain; no broker non-votes were cast because this was a routine matter.
• · Say-on-pay vote had 10,078,861 For, 4,938,131 Against, 87,770 Abstain, and 1,825,052 broker non-votes; the Against count represents strong opposition.

18-05-2026

This definitive proxy statement (DEF 14A) for Clough Global Opportunities Fund (GLO) calls for a joint annual meeting of shareholders on July 6, 2026. Shareholders are asked to elect two trustees (Karen A. DiGravio, Independent, and Kevin J. McNally, Interested) each for a three-year term expiring at the 2029 annual meeting. No financial performance or quantitative business data is provided in the filing.

• · Record date for voting: May 8, 2026.
• · Meeting date: July 6, 2026 at 9:00 a.m. Mountain Time (virtual telephone conference).
• · Shareholders must register by email by 5:00 p.m. ET on June 30, 2026 to participate.
• · Proxy materials available at https://www.proxy-direct.com/clo-35189.
• · Annual report for fiscal year ended October 31, 2025 is available upon request.
• · Each GLO share entitles holder to one vote per full share.
• · The Board is divided into three classes; nominees are for Class II (term expiring at 2029 annual meeting).

18-05-2026

Genco Shipping & Trading Ltd filed an amendment to its tender offer response (SC 14D9/A) reporting strong Q1 2026 financial results compared to a loss in Q1 2025. Net income swung to $9.3 million from a net loss of $11.9 million, and adjusted EBITDA surged over 350% to $36.2 million. However, daily vessel operating expenses rose 3.2% year-over-year, and the company recorded impairment charges of $0.5 million. The filing also reiterates management's solicitation of proxies for the 2026 Annual Meeting using a WHITE proxy card, amid an ongoing tender offer.

• · Net interest expense increased to $3.8M in Q1 2026 from $2.2M in Q1 2025.
• · Depreciation and amortization rose to $21.0M from $17.7M year-over-year.
• · Net gain on sale of vessels of $2.1M and other operating expense of $3.8M were recorded in Q1 2026 (none in Q1 2025).
• · Realized loss on fuel hedges of $40k in Q1 2026 vs a gain of $8k in Q1 2025.
• · The company provides estimated TCE for Q2 2026 (not quantified in filing) based on fixtures to date and FFA curve.
• · The filing is an amendment to a Schedule 14D-9, indicating an active tender offer; the company recommends shareholders vote the WHITE proxy card.

18-05-2026

ALEXANDER LABRUNERIE & CO., INC. filed its quarterly 13F-HR for the period ending March 31, 2026, reporting 151 equity holdings with a total market value of $267,451,075. The portfolio is diversified across major ETFs (e.g., Vanguard S&P 500 ETF, Vanguard Total Bond Market ETF) and individual stocks such as Apple, Microsoft, and Amazon. No prior period comparison is available in this filing, so performance trends cannot be assessed.

• · Total portfolio value of $267,451,075 across 151 positions
• · Largest positions likely include Vanguard S&P 500 ETF, Apple, Microsoft, Amazon, and NVIDIA based on typical institutional holdings.
• · The filing includes multiple share classes (e.g., Alphabet Class A and C, Berkshire Hathaway Class A and B) and a mix of domestic and international equities.
• · The portfolio contains a significant allocation to fixed income ETFs (e.g., Vanguard Intermediate-Term Treasury, Fidelity Total Bond, iShares TIPS) indicating a balanced strategy.

18-05-2026

Limbach Holdings announced the appointment of Michael Reed to the newly created position of Executive Vice President and Chief Operating Officer, effective May 18, 2026. Reed, a 7-year veteran of the company, most recently served as SVP Midwest Regional Manager and previously led integration of acquisitions including Consolidated Mechanical and Pioneer Power. The move aims to strengthen operational execution, support scalable growth, and drive a high-performance culture across the organization's 21 offices and 1,600 team members.

• · Michael Reed joined Limbach in 2019 as Vice President, Branch Manager.
• · Subsequent roles included Vice President of Operational Risk Management, Senior Vice President Integrations Leader (2024), and Senior Vice President Midwest Regional Manager (May 2025).
• · As COO, Reed will oversee both organic growth and strategic acquisitions, as well as culture and employee engagement.
• · The COO position is newly created, indicating a structural expansion of the executive team.

18-05-2026

NBT Bancorp Inc. filed an 8-K on May 18, 2026, disclosing that it will present at its 2026 Annual Meeting of Stockholders on May 19, 2026. The presentation slides are available on the company's website. This disclosure is made under Regulation FD and does not contain specific financial results or material non-public information.

• · The Form 8-K is filed under Item 7.01 Regulation FD Disclosure.
• · The presentation is scheduled for May 19, 2026, and slides are posted on the company's investor relations page.

18-05-2026

DevvStream Corp. reported in a May 12, 2026 filing that its prior merger agreement with Southern Energy Renewables Inc. has been automatically terminated following the execution of a new Business Combination Agreement (BCA) with XCF Global, Inc. and Southern. The BCA contemplates a complex transaction involving XCF acquiring DevvStream and Southern, with forward-looking targets including annualized revenue exceeding $1.0B and EBITDA above $100M, and a combined enterprise goal of $3.0B. However, the BCA remains subject to customary closing conditions, and no assurances are given that these conditions will be satisfied, while significant risks include potential Nasdaq delisting, delayed plant conversion, and uncertain bond issuance.

• · The Prior Merger Agreement (with Southern) automatically terminated upon expiration of Fairness Opinion Termination Rights, with no liability to any party.
• · The BCA includes three parties: DevvStream, XCF Global, and Southern, with two merger subsidiaries (DevvStream Merger Sub and Southern Merger Sub).
• · XCF will file a Form S-4 registration statement containing proxy statements/prospectus for stockholder votes.
• · Risk factors include XCF's ability to regain compliance with Nasdaq minimum bid price requirement, potential delays or failure of plant conversion, and uncertainties around Southern's bond issuance of up to $400M.

18-05-2026

On May 13, 2026, 60 Degrees Pharmaceuticals appointed Eric Francois to its Board of Directors, effective immediately. Francois is a seasoned healthcare and life sciences executive with over 20 years of experience, including roles as Managing Director at Raymond James and Credit Suisse, CFO of SCYNEXIS, and independent director roles. He will receive standard non-employee director compensation.

• · There are no arrangements or understandings between Mr. Francois and any other persons pursuant to which he was appointed as a director.
• · There are no family relationships between Mr. Francois and any director or executive officer of the Company.
• · Mr. Francois has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
• · Mr. Francois will receive compensation for his service on the Board consistent with the Company’s standard compensation arrangements for non-employee directors.

18-05-2026

Kiora Pharmaceuticals filed an S-3 registration statement with the SEC on May 18, 2026, to register 11,797,088 shares of common stock for resale by selling stockholders from an April 2026 private placement. The filing provides a business update on its lead product candidates KIO-301 (vision restoration) and KIO-104 (anti-inflammatory), highlighting significant licensing agreements with Théa Open Innovation (up to $285M milestones plus royalties) and Senju ($1.25M upfront, up to $109.5M milestones). However, the registration may lead to dilution, and the company remains a clinical-stage firm with no approved products on the market.

• · KIO-301 has received Orphan Drug Designation from the FDA (March 2022) and EMA (July 2024, expanded September 2024).
• · ABACUS-2 enrollment began in Q2 2025 following validation of novel functional vision endpoints.
• · KIO-104 is being developed for Diabetic Macular Edema and Posterior Non-Infectious Uveitis.
• · The Company will not receive any proceeds from the resale of shares by selling stockholders, but may receive proceeds from cash exercise of warrants.
• · The Company qualifies as a non-accelerated filer and a smaller reporting company.

18-05-2026

RB Global, Inc. (RBA) announced on May 18, 2026, that it has finalized its acquisition of Big Iron Auction Company. No financial terms or additional details were provided in the filing, which simply references an attached news release.

• · The acquisition of Big Iron Auction Company has been finalized as of May 18, 2026.
• · The filing does not disclose the purchase price or any expected financial impact.

18-05-2026

On May 18, 2026, Yale Transaction Finders, Inc. issued convertible promissory notes in the aggregate principal amount of $17,500 to three holders, including affiliates of its CEO and President/Treasurer. The notes carry 5% annual interest, mature on December 31, 2026, and are convertible upon a Qualified Financing or Fundamental Transaction. Proceeds will be used for working capital needs.

• · The notes were issued to Ironbound Partners Fund, LLC (affiliate of CEO), Moyo Partners, LLC (affiliate of President/Treasurer), and Dakota Group, LLC.
• · Conversion can occur upon a Qualified Financing or a Fundamental Transaction as defined in the notes.
• · The maturity date is December 31, 2026.
• · The filing does not disclose the exact number of shares issuable upon conversion.

18-05-2026